Neuroprotective effects of Ursodeoxy cholic-acid in comparison to Diazepam against Pilocarpine-induced status epilepticus in experimental rats
Abstract
Background: Epilepsy is the fourth most frequent neurological disorder worldwide. Epilepsy can be diagnosed if someone has two or more spontaneous seizures. Subtypes M1 and M3 of the receptor are affected by pilocarpine, with the M3 receptor having the ability to activate phospholipase C. In this way, the second messenger's inositol triphosphate, diacylglycerol, calcium, and protein kinase are produced. Because of this, M3 cholinergic agonists cause calcium to be upregulated, leading to smooth muscle contraction
Downloads
Published
Issue
Section
License
You are free to:
- Share — copy and redistribute the material in any medium or format for any purpose, even commercially.
- Adapt — remix, transform, and build upon the material for any purpose, even commercially.
- The licensor cannot revoke these freedoms as long as you follow the license terms.
Under the following terms:
- Attribution — You must give appropriate credit , provide a link to the license, and indicate if changes were made . You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
- No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
Notices:
You do not have to comply with the license for elements of the material in the public domain or where your use is permitted by an applicable exception or limitation .
No warranties are given. The license may not give you all of the permissions necessary for your intended use. For example, other rights such as publicity, privacy, or moral rights may limit how you use the material.
